(Q35142076)

6 August 2017

1 reference

title

Predictors of response in anxiety disorders (English)

1 reference

6 August 2017

H Brent Solvason

1

1 reference

PubMed ID

12778841

6 August 2017

Heidemarie Ernst

series ordinal

2

1 reference

PubMed ID

12778841

6 August 2017

Walton Roth

series ordinal

3

1 reference

6 August 2017

1 June 2003

1 reference

Psychiatric Clinics of North America

6 August 2017

1 reference

6 August 2017

26

1 reference

6 August 2017

411-433

1 reference

6 August 2017

2

1 reference

Follow-up studies in obsessional neurosis.

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

The epidemiology of generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Generalized anxiety disorder. An important clinical concern

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

DSM-III-R generalized anxiety disorder in the National Comorbidity Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Generalized anxiety disorder in women

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings: report from the World Health Organization Collaborative Study on Psychological Problems in General Health Care

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Comorbidity in generalized anxiety disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Phenomenology and course of generalised anxiety disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Patterns of Personality Pathology in Patients with Generalized Anxiety Disorder, Panic Disorder with and without Agoraphobia, and Social Phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Factors predicting the clinical course of generalised anxiety disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

A population-based twin study of generalized anxiety disorder in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Evidence for genetic influences common and specific to symptoms of generalized anxiety and panic.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

A twin study of generalized anxiety disorder symptoms, panic disorder symptoms and post-traumatic stress disorder in men

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

A review and meta-analysis of the genetic epidemiology of anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Superior temporal gyrus volumes in pediatric generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

A pilot study of amygdala volumes in pediatric generalized anxiety disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Epidemiology, patterns of comorbidity, and associated disabilities of social phobia.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Familial aggregation of anxiety-related quantitative traits in generalized social phobia: clues to understanding "disorder" heritability?

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Bringing up bashful baby. Developmental pathways to social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Genetic linkage to the serotonin transporter protein and 5HT2A receptor genes excluded in generalized social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Dopamine system genes not linked to social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Predictors of response to cognitive-behavioral group therapy for social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Prediction of treatment outcome in social phobia: a cross-validation

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

A Comparison of the Efficacy of Clonazepam and Cognitive-Behavioral Group Therapy for the Treatment of Social Phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Traumatic events and posttraumatic stress disorder in an urban population of young adults

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Post-traumatic stress disorder in the community: an epidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Psychiatric sequelae of posttraumatic stress disorder in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Hispanic ethnicity and risk for combat-related posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Peritraumatic dissociation and posttraumatic stress in male Vietnam theater veterans

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Clinical detection, diagnosis, and differential diagnosis of post-traumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Fluoxetine versus placebo in posttraumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

The epidemiology of obsessive-compulsive disorder in five US communities.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Natural history of obsessional states; a study of 150 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Clinical characteristics and family history in DSM-III obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Obsessive-compulsive disorder and depression. A retrospective study on course and interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Clinical predictors of drug response in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Comorbidity of mood and anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Effect of Axis II Diagnoses on Treatment Outcome With Clomipramine in 55 Patients With Obsessive-Compulsive Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Predictive value of obsessive-compulsive personality disorder in antiobsessional pharmacological treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Comorbidity of obsessive-compulsive disorder and depression: prevalence, symptom severity, and treatment effect

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

A family study of obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Predictors of response to pharmacotherapy with citalopram in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Side effects as predictors of drug response in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Obsessive-compulsive disorder in children and adolescents: predictors in childhood for long-term phenomenological course

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Long-term outcome and prognosis of obsessive-compulsive disorder with onset in childhood or adolescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Placebo-controlled trial of fluoxetine and phenelzine for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Cingulotomy for intractable obsessive-compulsive disorder. Prospective long-term follow-up of 18 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Obsessions and compulsions across time in 79 children and adolescents with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Obsessive-Compulsive Disorder, 5-HTTLPR polymorphism and treatment response.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Improvement predictors in obsessive-compulsive disorder. An event-related potential study

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

A voxel-based investigation of regional cerebral blood flow abnormalities in obsessive–compulsive disorder using single photon emission computed tomography (SPECT)

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0193-953X%2803%2900027-3

7 January 2021

10.1016/S0193-953X(03)00027-3

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12778841